What is AI Optics?
AI Optics operates at the intersection of ophthalmology and machine learning, specializing in the development of sophisticated diagnostic hardware and software. The company's flagship offering, the FDA-cleared Sentinel Camera, provides high-fidelity digital imaging of the human eye, facilitating rapid and accurate assessments. With the upcoming launch of the Sentinel Pro, the firm is expanding its capabilities to include automated screening for complex retinal conditions such as Diabetic Retinopathy and Glaucoma. By targeting primary care providers and large-scale health systems, AI Optics is effectively democratizing access to specialized diagnostic tools, ensuring that high-quality patient care is both scalable and cost-effective across diverse clinical environments.
How much funding has AI Optics raised?
AI Optics has raised a total of $14.7M across 1 funding round:
Private Equity
$14.7M
Private Equity (2025): $14.7M, investors not publicly disclosed
Key Investors in AI Optics
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for AI Optics?
With this major strategic investment, AI Optics is poised to accelerate its commercial expansion and R&D initiatives. The capital will likely be deployed to scale the distribution of the Sentinel Pro, further penetrating the primary care market and enhancing the software's diagnostic accuracy through iterative machine learning training. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward deepening its integration within existing electronic health record systems and expanding its footprint in international markets. This growth trajectory suggests a robust outlook for the firm as it continues to redefine the standards of point-of-care diagnostics through technological innovation.
See full AI Optics company page
